Search - tctmd.com

Displaying 341 - 360 of 383

Sort: Relevancy | Date

Presentation ESC 2014

Multicenter evaluation of a 1h-algorithm in the diagnosis of myocardial infarction using high-sensitivity cardiac Troponin T

Presenter: Christian Mueller

August 30, 2014

Presentation ESC 2014

Major improvement in one-year mortality in elderly patients admitted with AMI in relation with early PCI and recommended medications: data from the FAST-MI programme 1995-2010

Presenter: E. Puymirat

August 30, 2014

Presentation

Ethanol Infusion in the Vein of Marshall Leads to Parasympathetic Denervation of the Left Atrium

Presenter: J.L. B?ez-Escudero

February 20, 2014

Presentation TCT 2013

ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR

Presenter: Javier Escaned

October 30, 2013

Presentation

Mini-Review of the Latest ACC/AHA and ESC Guidelines on DAPT and PCI

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

Unraveling the ACS Culprit: Combined Findings with OCT and Microcirculatory Interrogation

Presenter: Javier Escaned

October 28, 2013

Presentation TCT 2013

Distilling the Aortic Stenosis Guidelines (Synthesis of ESC and ACC/AHA): Essentials and Controversies

Presenter: Alec Vahanian

October 27, 2013

Presentation

Critical Appraisal of the ESC 2013 Late Breaking Trials: TASTE, PRAMI and ACCOAST

Presenter: Gregg W. Stone

September 24, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

Presentation ESC 2013

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Presenter: Alvaro Avezum

September 03, 2013

Presentation ESC 2013

Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE trial)

Presenter: Ole Fr?bert

September 01, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

Presentation SOLACI 2013

Ischemia Driven Revascularisation: Will FAME Overcome SYNTAX?

Presenter: Javier Escaned

July 25, 2013

Presentation SOLACI 2013

Current Challenges in Multivessel and Left Main Percutaneous Coronary Interventions: Take Home Messages

Presenter: Javier Escaned

July 25, 2013

Presentation SOLACI 2013

Escore de Risco Para Avaliação de Pacientes Submetidos a ICP

Presenter: Angelita Paganin

July 24, 2013

Presentation CTO 2013

Equipment Entrapment

Presenter: Javier Escaned

February 21, 2013

Presentation

An Open Label Dose Escalation Study to Evaluate the Safety of Administration of Non-Viral SDF-1 Plasmid to Treat Symptomatic Ischemic Heart Failure

Presenter: 195098|Marc Penn

February 20, 2013

Presentation TCT 2013

The Instantaneous Wave-Free Ratio (iFR) and Fractional Flow Reserve (FFR) Have Equivalent Diagnostic Categorisation When Compared To Flow Based Indices

Presenter: Sayan Sen, Sukhjinder Nijjer, Ricardo Petraco, Kaleab Asrress, Christopher Broyd, Nicolas Foin, Rodney Foale, Iqbal Malik, Ghada Mikhail, Christopher Baker, Masood Khan, Muhammed Khawaja, Amarjit Sethi, Darrel Francis, Alun Hughes, Jamil Mayet, Carlo Di Mario, Javier Escaned, Simon Redwood, Justin Davies

January 31, 2013

Presentation TCT 2013

Does Adenosine Administration Improve Diagnostic Classification Of The Instantaneous Wave–Free Ratio (iFR)?

Presenter: Sayan Sen, Kaleab Asrress, Ricardo Petraco, Sukhjinder Nijjer, Christopher Broyd, Nicolas Foin, Rodney Foale, Iqbal Malik, Ghada Mikhail, Amarjit Sethi, Masood Khan, Muhammed Khawaja, Alun Hughes, Darrel Francis, Christopher Baker, Jamil Mayet, Carlo Di Mario, Javier Escaned, Simon Redwood, Justin Davies

January 31, 2013

Presentation

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Presenter: Emerson C. Perin

January 27, 2013

Advertisement

Multicenter evaluation of a 1h-algorithm in the diagnosis of myocardial infarction using high-sensitivity cardiac Troponin T

Major improvement in one-year mortality in elderly patients admitted with AMI in relation with early PCI and recommended medications: data from the FAST-MI programme 1995-2010

Ethanol Infusion in the Vein of Marshall Leads to Parasympathetic Denervation of the Left Atrium

ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR

Mini-Review of the Latest ACC/AHA and ESC Guidelines on DAPT and PCI

Unraveling the ACS Culprit: Combined Findings with OCT and Microcirculatory Interrogation

Distilling the Aortic Stenosis Guidelines (Synthesis of ESC and ACC/AHA): Essentials and Controversies

Critical Appraisal of the ESC 2013 Late Breaking Trials: TASTE, PRAMI and ACCOAST

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE trial)

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Ischemia Driven Revascularisation: Will FAME Overcome SYNTAX?

Current Challenges in Multivessel and Left Main Percutaneous Coronary Interventions: Take Home Messages

Escore de Risco Para Avaliação de Pacientes Submetidos a ICP

Equipment Entrapment

An Open Label Dose Escalation Study to Evaluate the Safety of Administration of Non-Viral SDF-1 Plasmid to Treat Symptomatic Ischemic Heart Failure

The Instantaneous Wave-Free Ratio (iFR) and Fractional Flow Reserve (FFR) Have Equivalent Diagnostic Categorisation When Compared To Flow Based Indices

Does Adenosine Administration Improve Diagnostic Classification Of The Instantaneous Wave–Free Ratio (iFR)?

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content